GLP-1 Weight Loss Drugs Devastate Zombie Food Supply, Industry in Crisis
The booming weight-loss drug market has triggered an unprecedented shortage in the zombie food supply chain, leaving reanimated consumers with dwindling options.
NECROTROPOLIS — The rapid adoption of GLP-1 receptor agonists among the living population has triggered what industry analysts are calling the most severe disruption to zombie food infrastructure since the Great Preservative Shortage of 1847. The Necronomic Advisory Group estimates that continued uptake of semaglutide and tirzepatide compounds could reduce available biomass by up to 34% within the next fiscal quarter.
"We are facing a caloric cliff," said Dr. Mortimer Gravewell, director of the Undead Nutrition Research Institute. "The average human has lost 17 pounds since 2023. That is 17 pounds of substrate that is no longer available to our consumers. The math is simple, and it is catastrophic."
The crisis has already forced several regional distributors into emergency rationing. Eternal Harvest LLC, the largest zombie food supplier in the Northeast Corridor, announced Thursday that it would suspend premium-tier deliveries and redirect inventory to essential services, including hospital morgue cafeterias and municipal reanimation centers.
The Zombie Food Workers Union, ZFWU Local 31, has called for emergency federal intervention, including subsidies for alternative protein development and a moratorium on GLP-1 prescriptions within designated feeding zones. "Our members are already working double shifts at half the caloric intake," said shop steward Rotwell Shamble. "Something has to give."
The Underworld Bureau of Labor Statistics confirmed that zombie food sector employment has declined 12% year-over-year, with further layoffs expected if current trends continue. The Vampire Council, which oversees inter-species commerce regulation, has scheduled an emergency session to address cross-sector supply chain implications.